A vs LPCN · P/E 29, rev $1.88B vs rev $11.2M
Agilent Technologies Inc (A) versus Lipocine Inc (LPCN) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
Latest reported A revenue for 2026-07-31 was $1.88B. Net income was $362.0M. Revenue was up 2.3% from 2026-04-30 to 2026-07-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
Latest reported LPCN revenue for 2024-12-31 was $11.2M. Net income was $8.4K. Revenue was up 492.8% from 2023-12-31 to 2024-12-31. LPCN currently screens at market cap $19.3M.
A currently screens at market cap $33.70B and trailing P/E 29.2. LPCN currently screens at market cap $19.3M.
Not investment advice. Open the A and LPCN stock pages for the full models.
Not investment advice.